After interviewing an HIV-positive patient who is considering starting highly active antiretroviral therapy (HAART), which patient information concerns you the most?

• A. The patient has been HIV positive for 8 years and has never taken any drug therapy for the HIV infection.
• B. The patient tells you, "I have never been very consistent about taking medications."
• C. The patient is sexually active with multiple partners and says "I always use a condom."
• D. The patient has many questions and concerns regarding the effectiveness and safety of the medications.

Answer: (B)

Adherence to antiretroviral therapy is essential for keeping HIV suppressed and preventing the virus from developing resistance. HAART works best when taken exactly as prescribed every day; if doses are missed, the virus can rebound quickly and resistance can develop, compromising future treatment options. The most concerning information is the patient’s admission of never being consistent about taking medications, because this strongly predicts poor adherence to a lifelong regimen and poses a high risk for treatment failure from the start. The priority is to assess barriers to adherence and implement support strategies—simplifying the regimen if possible, using reminders or pill organizers, and involving support systems—so the patient can maintain consistent daily dosing. The other details—condom use with multiple partners and asking many questions about safety and effectiveness—do not indicate an immediate adherence risk and can guide counseling and education rather than highlighting an imminent threat to HAART success.